Insulin and associated medical devices: what are the key regulatory challenges today?

Ensuring equitable access to insulin and associated medical devices remains a major global health priority. Despite significant medical advances, many countries continue to face regulatory, procurement, and market challenges that limit the availability, affordability, and quality assurance of diabetes care products.

In this video, Cécile Macé examines the evolving regulatory landscape surrounding insulin and diabetes-related medical devices. The discussion explores the role of regulatory authorities, quality standards, market approval pathways, pharmacovigilance mechanisms, and procurement systems in supporting safe and effective access to care. The webinar also reflects on broader health system implications, including the need for stronger governance, regulatory harmonisation, and sustainable access strategies, particularly in low- and middle-income settings.

Researchers, policymakers, civil society actors, and health professionals are encouraged to engage with the discussion and contribute to advancing evidence-informed approaches to diabetes care and NCD policy.